Luke M. Reilly
Associate | Philadelphia
Luke M. Reilly

Luke M. Reilly represents clients in a variety of intellectual property and commercial matters, focusing primarily on litigating patent and trade secret claims. His experience spans technology areas, ranging from wireless cellular systems to pharmaceutical compositions to printing technology. He has experience in all phases of litigation, including factual investigation, drafting complaints and answers, preparing motion and declarations, discovery, Markman briefing, working with experts and expert testimony, taking fact and expert depositions, pre- and post-trial briefing, appellate briefing, and appearing at oral argument in the United States Court of Appeals for the Federal Circuit.

Mr. Reilly also maintains an active pro bono practice, working with Philadelphia VIP to assist tenants involved in landlord-tenant disputes in Philadelphia Municipal Court.

  • Phyto Tech Corp. v. Givaudan SA (S.D.N.Y.). Represented synthetic biology company in trade secret misappropriation and breach of contract action. After a bench trial, the Court found that the defendant had breached the confidentiality agreement with our client and awarded attorneys’ fees.
  • Par Pharmaceutical, Inc. et al. v. Eagle Pharmaceuticals Inc. (D. Del.). Represented Par Pharmaceutical, Inc. in Hatch-Waxman case filed against multiple generic companies involving Par’s VASOSTRICT® (vasopressin) product.
  • Trinity Graphic, USA, Inc. v. Tervis Tumbler Co. et al. (M.D. Fla.) Represented SGS International as defendant in trade secret litigation relating to printing technologies for tumbler inserts. Case settled with Plaintiff dropping all claims against our client.
  • Intellectual Ventures I LLC v. T-Mobile USA, Inc. et al. (E.D. Tex.).  Represented Intellectual Ventures in patent infringement action involving wireless LTE technology. Following trial, the jury found client’s patents valid and infringed.
  • Jazz Pharmaceuticals, Inc. v. Synchrony Group, LLC et al. (E.D. Pa.). Represented Jazz Pharmaceuticals in trade secret dispute regarding industry knowledge provided confidentially to marketing agent.
  • Dechert Secures Complete Victory for IOENGINE in IPR Proceedings - (May 10, 2023)
  • Fed. Circ. Ruling Can Serve To Guide Patent Range Claims - Law360 (May 9, 2023)
  • Dechert Secures Favorable Decisions in Two IPR Proceedings for IOENGINE - (February 10, 2023)
  • Dechert IP Litigation Team Victory - (July 18, 2022)
  • Is Stricter Federal Circuit Review of IPR Factfinding on the Horizon? - (October 25, 2019)
    • Columbia Law School, J.D., 2017
    • University of Pennsylvania, B.A., 2011
    • Commonwealth of Pennsylvania
    • United States Court of Appeals for the Federal Circuit
    • United States District Court for the Eastern District of Pennsylvania